PTPRZ1 and Alzheimer disease: Based on these considerations, we aim to demonstrate that RPTPβ/ζ modulates neuroinflammation and neurodegeneration, using the selective inhibitor of RPTPβ/ζ, MY10, in a mouse model of AD.